COVID-19 Impact on Global B-cell lymphoma 2 Inhibitors Market Size, Status and Forecast 2020-2026

August 2020 | 92 pages | ID: C259130D24ABEN
QYResearch

Abstracts

This report focuses on the global B-cell lymphoma 2 Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the B-cell lymphoma 2 Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AbbVie Inc.
• F. Hoffmann-La Roche Ltd.
• Santa Cruz Biotechnology
• Tocris
• Biovision
• ...

Market segment by Type, the product can be split into

• Combination Therapy
• Monotherapy

Market segment by Application, split into

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma
• Cute Myeloid Leukemia

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global B-cell lymphoma 2 Inhibitors status, future forecast, growth opportunity, key market and key players.
• To present the B-cell lymphoma 2 Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of B-cell lymphoma 2 Inhibitors are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by B-cell lymphoma 2 Inhibitors Revenue
1.4 Market Analysis by Type
  1.4.1 Global B-cell lymphoma 2 Inhibitors Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Combination Therapy
  1.4.3 Monotherapy
1.5 Market by Application
  1.5.1 Global B-cell lymphoma 2 Inhibitors Market Share by Application: 2020 VS 2026
  1.5.2 Chronic Lymphocytic Leukemia
  1.5.3 Small Lymphocytic Lymphoma
  1.5.4 Cute Myeloid Leukemia
1.6 Coronavirus Disease 2019 (Covid-19): B-cell lymphoma 2 Inhibitors Industry Impact
  1.6.1 How the Covid-19 is Affecting the B-cell lymphoma 2 Inhibitors Industry
    1.6.1.1 B-cell lymphoma 2 Inhibitors Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and B-cell lymphoma 2 Inhibitors Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for B-cell lymphoma 2 Inhibitors Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 B-cell lymphoma 2 Inhibitors Market Perspective (2015-2026)
2.2 B-cell lymphoma 2 Inhibitors Growth Trends by Regions
  2.2.1 B-cell lymphoma 2 Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 B-cell lymphoma 2 Inhibitors Historic Market Share by Regions (2015-2020)
  2.2.3 B-cell lymphoma 2 Inhibitors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 B-cell lymphoma 2 Inhibitors Market Growth Strategy
  2.3.6 Primary Interviews with Key B-cell lymphoma 2 Inhibitors Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top B-cell lymphoma 2 Inhibitors Players by Market Size
  3.1.1 Global Top B-cell lymphoma 2 Inhibitors Players by Revenue (2015-2020)
  3.1.2 Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Players (2015-2020)
  3.1.3 Global B-cell lymphoma 2 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global B-cell lymphoma 2 Inhibitors Market Concentration Ratio
  3.2.1 Global B-cell lymphoma 2 Inhibitors Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by B-cell lymphoma 2 Inhibitors Revenue in 2019
3.3 B-cell lymphoma 2 Inhibitors Key Players Head office and Area Served
3.4 Key Players B-cell lymphoma 2 Inhibitors Product Solution and Service
3.5 Date of Enter into B-cell lymphoma 2 Inhibitors Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global B-cell lymphoma 2 Inhibitors Historic Market Size by Type (2015-2020)
4.2 Global B-cell lymphoma 2 Inhibitors Forecasted Market Size by Type (2021-2026)

5 B-CELL LYMPHOMA 2 INHIBITORS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020)
5.2 Global B-cell lymphoma 2 Inhibitors Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America B-cell lymphoma 2 Inhibitors Market Size (2015-2020)
6.2 B-cell lymphoma 2 Inhibitors Key Players in North America (2019-2020)
6.3 North America B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020)
6.4 North America B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe B-cell lymphoma 2 Inhibitors Market Size (2015-2020)
7.2 B-cell lymphoma 2 Inhibitors Key Players in Europe (2019-2020)
7.3 Europe B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020)
7.4 Europe B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020)

8 CHINA

8.1 China B-cell lymphoma 2 Inhibitors Market Size (2015-2020)
8.2 B-cell lymphoma 2 Inhibitors Key Players in China (2019-2020)
8.3 China B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020)
8.4 China B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan B-cell lymphoma 2 Inhibitors Market Size (2015-2020)
9.2 B-cell lymphoma 2 Inhibitors Key Players in Japan (2019-2020)
9.3 Japan B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020)
9.4 Japan B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size (2015-2020)
10.2 B-cell lymphoma 2 Inhibitors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020)
10.4 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020)

11 INDIA

11.1 India B-cell lymphoma 2 Inhibitors Market Size (2015-2020)
11.2 B-cell lymphoma 2 Inhibitors Key Players in India (2019-2020)
11.3 India B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020)
11.4 India B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America B-cell lymphoma 2 Inhibitors Market Size (2015-2020)
12.2 B-cell lymphoma 2 Inhibitors Key Players in Central & South America (2019-2020)
12.3 Central & South America B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020)
12.4 Central & South America B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AbbVie Inc.
  13.1.1 AbbVie Inc. Company Details
  13.1.2 AbbVie Inc. Business Overview and Its Total Revenue
  13.1.3 AbbVie Inc. B-cell lymphoma 2 Inhibitors Introduction
  13.1.4 AbbVie Inc. Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020))
  13.1.5 AbbVie Inc. Recent Development
13.2 F. Hoffmann-La Roche Ltd.
  13.2.1 F. Hoffmann-La Roche Ltd. Company Details
  13.2.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
  13.2.3 F. Hoffmann-La Roche Ltd. B-cell lymphoma 2 Inhibitors Introduction
  13.2.4 F. Hoffmann-La Roche Ltd. Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020)
  13.2.5 F. Hoffmann-La Roche Ltd. Recent Development
13.3 Santa Cruz Biotechnology
  13.3.1 Santa Cruz Biotechnology Company Details
  13.3.2 Santa Cruz Biotechnology Business Overview and Its Total Revenue
  13.3.3 Santa Cruz Biotechnology B-cell lymphoma 2 Inhibitors Introduction
  13.3.4 Santa Cruz Biotechnology Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020)
  13.3.5 Santa Cruz Biotechnology Recent Development
13.4 Tocris
  13.4.1 Tocris Company Details
  13.4.2 Tocris Business Overview and Its Total Revenue
  13.4.3 Tocris B-cell lymphoma 2 Inhibitors Introduction
  13.4.4 Tocris Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020)
  13.4.5 Tocris Recent Development
13.5 Biovision
  13.5.1 Biovision Company Details
  13.5.2 Biovision Business Overview and Its Total Revenue
  13.5.3 Biovision B-cell lymphoma 2 Inhibitors Introduction
  13.5.4 Biovision Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020)
  13.5.5 Biovision Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. B-cell lymphoma 2 Inhibitors Key Market Segments
Table 2. Key Players Covered: Ranking by B-cell lymphoma 2 Inhibitors Revenue
Table 3. Ranking of Global Top B-cell lymphoma 2 Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global B-cell lymphoma 2 Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Combination Therapy
Table 6. Key Players of Monotherapy
Table 7. COVID-19 Impact Global Market: (Four B-cell lymphoma 2 Inhibitors Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for B-cell lymphoma 2 Inhibitors Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for B-cell lymphoma 2 Inhibitors Players to Combat Covid-19 Impact
Table 12. Global B-cell lymphoma 2 Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global B-cell lymphoma 2 Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global B-cell lymphoma 2 Inhibitors Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global B-cell lymphoma 2 Inhibitors Market Share by Regions (2015-2020)
Table 16. Global B-cell lymphoma 2 Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global B-cell lymphoma 2 Inhibitors Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. B-cell lymphoma 2 Inhibitors Market Growth Strategy
Table 22. Main Points Interviewed from Key B-cell lymphoma 2 Inhibitors Players
Table 23. Global B-cell lymphoma 2 Inhibitors Revenue by Players (2015-2020) (Million US$)
Table 24. Global B-cell lymphoma 2 Inhibitors Market Share by Players (2015-2020)
Table 25. Global Top B-cell lymphoma 2 Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-cell lymphoma 2 Inhibitors as of 2019)
Table 26. Global B-cell lymphoma 2 Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players B-cell lymphoma 2 Inhibitors Product Solution and Service
Table 29. Date of Enter into B-cell lymphoma 2 Inhibitors Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 32. Global B-cell lymphoma 2 Inhibitors Market Size Share by Type (2015-2020)
Table 33. Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Type (2021-2026)
Table 34. Global B-cell lymphoma 2 Inhibitors Market Size Share by Application (2015-2020)
Table 35. Global B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 36. Global B-cell lymphoma 2 Inhibitors Market Size Share by Application (2021-2026)
Table 37. North America Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$)
Table 38. North America Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020)
Table 39. North America B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 40. North America B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020)
Table 41. North America B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 42. North America B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020)
Table 43. Europe Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020)
Table 45. Europe B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 46. Europe B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020)
Table 47. Europe B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 48. Europe B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020)
Table 49. China Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$)
Table 50. China Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020)
Table 51. China B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 52. China B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020)
Table 53. China B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 54. China B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020)
Table 55. Japan Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020)
Table 57. Japan B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 58. Japan B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020)
Table 59. Japan B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 60. Japan B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020)
Table 63. Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020)
Table 65. Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020)
Table 67. India Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$)
Table 68. India Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020)
Table 69. India B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 70. India B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020)
Table 71. India B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 72. India B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020)
Table 73. Central & South America Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020)
Table 75. Central & South America B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020)
Table 77. Central & South America B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020)
Table 79. AbbVie Inc. Company Details
Table 80. AbbVie Inc. Business Overview
Table 81. AbbVie Inc. Product
Table 82. AbbVie Inc. Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) (Million US$)
Table 83. AbbVie Inc. Recent Development
Table 84. F. Hoffmann-La Roche Ltd. Company Details
Table 85. F. Hoffmann-La Roche Ltd. Business Overview
Table 86. F. Hoffmann-La Roche Ltd. Product
Table 87. F. Hoffmann-La Roche Ltd. Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) (Million US$)
Table 88. F. Hoffmann-La Roche Ltd. Recent Development
Table 89. Santa Cruz Biotechnology Company Details
Table 90. Santa Cruz Biotechnology Business Overview
Table 91. Santa Cruz Biotechnology Product
Table 92. Santa Cruz Biotechnology Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) (Million US$)
Table 93. Santa Cruz Biotechnology Recent Development
Table 94. Tocris Company Details
Table 95. Tocris Business Overview
Table 96. Tocris Product
Table 97. Tocris Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) (Million US$)
Table 98. Tocris Recent Development
Table 99. Biovision Company Details
Table 100. Biovision Business Overview
Table 101. Biovision Product
Table 102. Biovision Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) (Million US$)
Table 103. Biovision Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global B-cell lymphoma 2 Inhibitors Market Share by Type: 2020 VS 2026
Figure 2. Combination Therapy Features
Figure 3. Monotherapy Features
Figure 4. Global B-cell lymphoma 2 Inhibitors Market Share by Application: 2020 VS 2026
Figure 5. Chronic Lymphocytic Leukemia Case Studies
Figure 6. Small Lymphocytic Lymphoma Case Studies
Figure 7. Cute Myeloid Leukemia Case Studies
Figure 8. B-cell lymphoma 2 Inhibitors Report Years Considered
Figure 9. Global B-cell lymphoma 2 Inhibitors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global B-cell lymphoma 2 Inhibitors Market Share by Regions: 2020 VS 2026
Figure 11. Global B-cell lymphoma 2 Inhibitors Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global B-cell lymphoma 2 Inhibitors Market Share by Players in 2019
Figure 14. Global Top B-cell lymphoma 2 Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-cell lymphoma 2 Inhibitors as of 2019
Figure 15. The Top 10 and 5 Players Market Share by B-cell lymphoma 2 Inhibitors Revenue in 2019
Figure 16. North America B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. AbbVie Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AbbVie Inc. Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2015-2020)
Figure 25. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2015-2020)
Figure 27. Santa Cruz Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Santa Cruz Biotechnology Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2015-2020)
Figure 29. Tocris Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Tocris Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2015-2020)
Figure 31. Biovision Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Biovision Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed